ISHARES U.S. PHARMACEUTICALS ETF

Each fund name links to that filer's expert page. Share counts and per-fund weights are pending the 13F ingest fix (portfolios_expertholding.units is currently mis-populated — see the same caveat on the fund detail page's holdings table). Quarter-over-quarter delta ships with the metrics pipeline.

See all 188 13F holders · Pro →

Smart Money · top-200 alpha cohort

2 holders · Q1 2026

Fewer than 3 top-performer holders hold this ticker — not enough signal for a Smart-Money commentary this week. The institutional holders table below shows the full picture.

CV Advisors LLC

0.01% held

α +29.1pts

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

0.00% held

α +27.5pts

Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.

Insider activity · last 90 days

No insider activity

No Form 4 filings on record for $IHE in the recent window.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $IHE in the recent window.

Convergence · Pattern Engine ships in v1.1

30-day window

In development

Convergence detection for $IHE lands with the Pattern Engine.

Once the Pattern Engine ships, this section will surface every active convergence event involving $IHE — the institutional managers and Congress members on the same name, the 30-day window, and the combined position size.

Source data: SEC EDGAR · 13F-HR · Form 4 · CapitolTrades · Last refreshed 16:16 UTC.